“The long run is psychedelic,” declared Rick Doblin, founding father of Lykos Therapeutics, at a convention on psychedelic medication remaining 12 months. A number of research, lots of them funded via Lykos, had supplied tantalising indicators that pairing MDMA with communicate remedy may just dramatically scale back signs of post-traumatic rigidity dysfunction (PTSD). Consequently, Doblin was once one of the advocates touting the drug as key to revolutionising psychological healthcare.
However only a 12 months later,…